Stereotactic MRI-guided adaptive radiation therapy shows promise for treating pancreatic cancer

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.

Related Keywords

Michigan ,United States ,Ben Movsas ,Parag Parikh ,Henry Ford ,David Kwon ,Emily Henderson ,Henry Ford Health Cancer ,Henry Ford Health ,Henry Ford Pancreatic Cancer Center ,Guided On Table Adaptive Radiation Therapy ,Locally Advanced Pancreatic Cancer ,Guided Radiation Therapy ,Medical Director ,Annual Meeting ,American Society ,Radiation Oncology ,Principal Investigator ,Clinical Director ,Ford Health Cancer ,Cancer ,Pancreatic Cancer ,Radiation Therapy ,Cancer Treatment ,Medicine ,Ncology ,Rthopedics ,Research ,Sports Medicine ,